selective estrogen receptor modulator (SERM)

Tamoxifen - Toremifene      

pathologytreatmentpatient Demonstrated benefit and harm k      
advanced breast cancer (metastatic)tamoxifennot classified

versus

No demonstrated result for efficacy

22 trialsmeta-analysis
advanced breast cancer (metastatic)toremifene not classified

versus

No demonstrated result for efficacy

6 trialsmeta-analysis